Company Monitoring Page for Roche

latest headlines for company on cafepharma

Pfizer, Roche and Aspen face South African probe into cancer drug prices
Reuters
Tue, 06/13/17 - 04:30 pm
Tags:
Pfizer, Roche, Aspen Pharmacare, South Africa, drug pricing
Roche ditches work on NewLink’s IDO cancer candidate
Fierce Biotech
Thu, 06/8/17 - 09:39 am
Tags:
Roche, NewLink Genetics, indoximod, metastatic breast cancer
ASCO17: Roche's Alecensa bests Xalkori in lung study
BioPharma Dive
Mon, 06/5/17 - 12:11 pm
Tags:
Roche, Alecensa, Xalkori, ASCO 2017, Pfizer, lung cancer
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Fierce Pharma
Mon, 06/5/17 - 12:08 pm
Tags:
Takeda, Roche, ALK inhibitors, ASCO 2017, lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Tags:
Novartis, Zykadia, Pfizer, Xalkori, Roche, Alecensa, non-small cell lung cancer
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
Tags:
FDA, Roche, Ocrevus, Puma Biotechnology, neratinib, Novartis
Roche launches Accu-Chek Guide blood glucose meter
Mass Device
Tue, 05/30/17 - 10:04 am
Tags:
Roche, devices, blood glucose monitoring, glucose meters, Accu-Chek
Roche looks into PML report for Ocrevus patient
BioPharma Dive
Thu, 05/25/17 - 11:25 am
Tags:
Roche, PML, Ocrevus, Genentech, MS, multiple sclerosis
Roche debuts latest blood glucose meter, savings program
Fierce Biotech
Wed, 05/24/17 - 10:52 am
Tags:
Roche, devices, blood glucose monitoring, diabetes, Accu-Chek
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
RAPS.org
Mon, 05/22/17 - 12:47 pm
Tags:
Roche, Actemra, FDA, giant cell arteritis, tocilizumab
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
Tags:
ASCO 2017, oncology, Incyte, Merck, Eli Lilly, CAR-T, NewLink Genetics, Amgen, Roche, Kite Pharma, Juno Therapeutics
Merck’s checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
Endpoints
Fri, 05/19/17 - 10:12 am
Tags:
Merck, Keytruda, FDA, Roche, Tecentriq
In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study
Endpoints
Wed, 05/10/17 - 10:13 am
Tags:
Roche, Tecentriq, clinical trials, bladder cancer
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Tags:
Roche, biosimilars, Rituxan, Herceptin, Avastin
Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Endpoints
Thu, 04/27/17 - 09:25 am
Tags:
Roche, Seragon, earnings, breast cancer
Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
Tags:
earnings, AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Roche, Sanofi
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Fierce Pharma
Wed, 04/19/17 - 04:21 pm
Tags:
earnings, drug pricing, Bristol-Myers Squibb, AbbVie, Roche
Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer
Fierce Pharma
Tue, 04/18/17 - 09:00 pm
Tags:
Roche, Tecentriq, bladder cancer, FDA
Roche claims that its interim update on hemophilia A drug is positive. But it’s hard to gauge.
Endpoints
Mon, 04/17/17 - 11:07 am
Tags:
Roche, hemophilia A, emicizumab
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
Tags:
drug discounts, drug pricing, Roche, Neurocrine, Sanofi, Regeneron, Tesaro, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.